Targeting of Cyclic AMP Degradation to β <sub>2</sub> -Adrenergic Receptors by β-Arrestins

Stephen J. Perry(Howard Hughes Medical Institute), George S. Baillie(University of Glasgow), Trudy A. Kohout(Howard Hughes Medical Institute), Ian McPhee(University of Glasgow), Maria M. Magiera(University of Glasgow), Kok Long Ang(Stanford Medicine), William E. Miller(Howard Hughes Medical Institute), Alison J. McLean(University of Glasgow), Marco Conti(Stanford Medicine), Miles D. Houslay(University of Glasgow), Robert J. Lefkowitz(Howard Hughes Medical Institute)
Science
October 24, 2002
Cited by 498

Abstract

Catecholamines signal through the beta2-adrenergic receptor by promoting production of the second messenger adenosine 3',5'-monophosphate (cAMP). The magnitude of this signal is restricted by desensitization of the receptors through their binding to beta-arrestins and by cAMP degradation by phosphodiesterase (PDE) enzymes. We show that beta-arrestins coordinate both processes by recruiting PDEs to activated beta2-adrenergic receptors in the plasma membrane of mammalian cells. In doing so, the beta-arrestins limit activation of membrane-associated cAMP-activated protein kinase by simultaneously slowing the rate of cAMP production through receptor desensitization and increasing the rate of its degradation at the membrane.


Related Papers

No related papers found

Powered by citation graph analysis